← All trials
NCT04957212
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 11, 2018
- Primary completion
- May 27, 2020
- Completion date
- May 27, 2020
- First posted
- Jul 12, 2021
- Last posted
- Sep 5, 2021
- Enrollment
- 214
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- CinnagenLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.